[HTML][HTML] Advances in siRNA Drug Delivery Strategies for Targeted TNBC Therapy
MA Subhan, VP Torchilin - Bioengineering, 2024 - mdpi.com
Among breast cancers, triple-negative breast cancer (TNBC) has been recognized as the
most aggressive type with a poor prognosis and low survival rate. Targeted therapy for …
most aggressive type with a poor prognosis and low survival rate. Targeted therapy for …
[HTML][HTML] Cell death: mechanisms and potential targets in breast cancer therapy
J Qian, L Zhao, L Xu, J Zhao, Y Tang, M Yu… - International Journal of …, 2024 - mdpi.com
Breast cancer (BC) has become the most life-threatening cancer to women worldwide, with
multiple subtypes, poor prognosis, and rising mortality. The molecular heterogeneity of BC …
multiple subtypes, poor prognosis, and rising mortality. The molecular heterogeneity of BC …
Triple negative breast cancer metastasis is hindered by a peptide antagonist of F11R/JAM‑A protein
R Bednarek, DW Wojkowska, M Braun, C Watala… - Cancer Cell …, 2023 - Springer
Abstract Background The F11R/JAM-A cell adhesion protein was examined as the
therapeutic target in triple negative breast cancer (TNBC) with the use of the peptide …
therapeutic target in triple negative breast cancer (TNBC) with the use of the peptide …
Enhancing breast cancer treatment through pharmacogenomics: A narrative review
RMR Kumar, S Joghee - Clinica Chimica Acta, 2024 - Elsevier
Pharmacogenomics has become integral to personalised medicine in breast cancer,
utilising genetic insights to customize treatment strategies and enhance patient outcomes …
utilising genetic insights to customize treatment strategies and enhance patient outcomes …
Clinical and biological significance of microRNA-127 and microRNA-138 expression in women with breast cancer: response to treatment and survival impact
Abstract Background and Objective Genetic and epigenetic changes characterize the multi-
step process of breast carcinogenesis. It is believed that abnormal microRNA (miRNA) …
step process of breast carcinogenesis. It is believed that abnormal microRNA (miRNA) …
Targeting Myeloid Determinants of Breast Cancer
C Kudo-Saito, Y Ozaki - 2024 - Springer
Breast cancer (BC) is the most commonly diagnosed cancer in women worldwide and the
second largest cause of cancer-related deaths. Recently, numerous agents, including …
second largest cause of cancer-related deaths. Recently, numerous agents, including …
Research on therapeutic clinical trials including immunotherapy in Triple-negative Breast cancer: A bibliometric analysis
Q Xu, X Feng, S Qin, Y Hong, R Cui, J Liang, Z Xiao… - 2024 - researchsquare.com
Background Breast cancer is a common malignancy worldwide. Triple-negative breast
cancer (TNBC) is a prevalent subtype of breast cancer that has poorer histological …
cancer (TNBC) is a prevalent subtype of breast cancer that has poorer histological …